Similar Search Results

Price Indices and the Value of Innovation with Heterogenous Patients

Lucarelli, Claudio; Nicholson, Sean; Tilipman, Nicholas - 2022

Many countries use uniform cost-effectiveness criteria to determine whether to adopt a new medical technology for the entire population. This approach assumes homogeneous preferences for expected health benefits and side effects. We examine whether new prescription drugs generate welfare gains...

Persistent link: https://www.econbiz.de/10014241448

Cost-Effectiveness of 23-Valent Pneumococcal Vaccine in Catalonia (Spain)

Plans-Rubio, Pedro - 2007

OBJECTIVE: In this study, cost-effectiveness of the 23-valent pneumococcal vaccination was assessed in Catalonia (Spain). METHODS: Cost-effectiveness was measured in terms of cost per life year gained (LYG), comparing net program costs and effectiveness. The net program cost was calculated from...

Persistent link: https://www.econbiz.de/10014055624

Costs and benefits of branded drugs : insights from cost-effectiveness research

Frech, Henry Edward; Pauly, Mark V.; Comanor, William S.; … - In: Journal of benefit-cost analysis : JBCA 13 (2022) 2, pp. 166-181

The relationship between costs and health benefits of branded pharmaceuticals remains controversial. This paper … branded pharmaceuticals with both higher costs and increased effectiveness compared to the previous standard of care … the variation in the cost of pharmaceuticals is, therefore, not random but rather associated with variation in QALYs …

Persistent link: https://www.econbiz.de/10013366987

Price indices and the value of innovation with heterogenous patients

Lucarelli, Claudio; Nicholson, Sean; Tilipman, Nicholas - In: Journal of health economics 84 (2022), pp. 1-33

Persistent link: https://www.econbiz.de/10013400016

Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting : the case of Thailand at start of the pandemic

Wang, Yi; Nantasit Luangasanatip; Wirichada Pan–ngum; … - In: The European journal of health economics 24 (2023) 5, pp. 735-748

Persistent link: https://www.econbiz.de/10014328090

The cost-effectiveness of a uniform versus age-based threshold for one-off screening for prevention of cardiovascular disease

Špacírová, Zuzana; Kaptoge, Stephen; … - In: The European journal of health economics 24 (2023) 7, pp. 1033-1045

Persistent link: https://www.econbiz.de/10014328169

The price of cost-effectiveness thresholds

Brekke, Kurt R.; Dalen, Dag Morten; Straume, Odd Rune - 2023

Persistent link: https://www.econbiz.de/10014297008

The price of cost-effectiveness thresholds under therapeutic competition in pharmaceutical markets

Brekke, Kurt R.; Dalen, Dag Morten; Straume, Odd Rune - In: Journal of health economics 90 (2023), pp. 1-17

Persistent link: https://www.econbiz.de/10014426057

Country versus pharmaceutical company interests for hepatitis C treatment

Lothan, Roy; Gutman, Noa; Yamin, Dan - In: Health care management science : a new journal serving … 25 (2022) 4, pp. 725-749

Persistent link: https://www.econbiz.de/10013483722

Cost-effectiveness of women's vaccination against HPV : results for the Czech Republic

Lušková, Martina; Bortnikova, Kseniya - 2024

This paper evaluates the cost-effectiveness of vaccinating women against human papillomaviruses (HPV) in the Czech Republic, where HPV is the main cause of most cervical carcinomas. It examines the cost-effectiveness of the current reimbursement policy for HPV vaccination compared to the...

Persistent link: https://www.econbiz.de/10014521062